SOHO Brazil

 

SOHO Brazil 2023
J

2023 SOHO® Brazil: "Moving Beyond CODOX - How Disease Features Can Guide Treatment in Burkitt Lymphoma"

By SOHO Brazil 2023 FEATURING Juan Alderuccio
By SOHO Brazil 2023 FEATURING Juan Alderuccio
78 views
August 8, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
SOHO Brazil 2023
20:58
SOHO Brazil 2023

2023 SOHO® Brazil: "Why Should I Worry About the Complexity of …

Feat. J. Abramson
14:03
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond CODOX - How Disease Features …

Feat. J. Alderuccio
24:43
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond R-CHOP - How Disease Features…

Feat. J. Abramson
20:02
SOHO Brazil 2023

2023 SOHO® Brazil: "Are We About to Abandon Transplantation in …

Feat. J. Abramson
18:51
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond the Deauville Scale in Lympho…

Feat. J. Alderuccio
18:10
SOHO Brazil 2023

2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Feat…

Feat. A. Moskowitz
23:24
SOHO Brazil 2023

2023 SOHO® Brazil: "How I Sequence New Agents in First and Seco…

Feat. A. Moskowitz
18:35
SOHO Brazil 2023

2023 SOHO® Brazil: "Problems on the Horizon - When MZL Goes Bad…

Feat. J. Alderuccio
14:39
SOHO Brazil 2023

2023 SOHO® Brazil: "Does MCL Want to Become CLL When It Grows U…

Feat. A. Danilov
19:21
SOHO Brazil 2023

2023 SOHO® Brazil: "CAR-T Therapy in MCL, FL, and MZL"

Feat. B. Shah
15:25
SOHO Brazil 2023

2023 SOHO® Brazil: "Are We About to Abandon Transplantation in …

Feat. B. Shah
15:53
SOHO Brazil 2023

2023 SOHO® Brazil: "Treating First and Second Line Follicular L…

Feat. J. Alderuccio
12:19
SOHO Brazil 2023

2023 SOHO® Brazil: "Are We About to Abandon Transplant in HL?&q…

Feat. A. Moskowitz
23:05
SOHO Brazil 2023

[Portugese] 2023 SOHO® Brazil: "Paradigm Shift in the Treatment…

Feat. A. De Almeida
45:12
SOHO Brazil 2023

[Portugese] 2023 SOHO® Brazil: "JAK2i Combination Therapies in …

Feat. A. De Almeida
27:42
SOHO Brazil 2023

[Portugese] 2023 SOHO® Brazil: "CML Treatment Beyond 2nd Genera…

Feat. A. De Almeida
17:41
SOHO Brazil 2023

[Portugese] 2023 SOHO® Brazil: "MDS/MPN Overlap Syndromes"

Feat. A. De Almeida
16:49
SOHO Brazil 2023

2023 SOHO® Brazil: "The Challenge in Treatment of T-ALL"

Feat. B. Shah
19:43
SOHO Brazil 2023

2023 SOHO® Brazil: "Will Ph+ ALL Be the First ALL Subtype to Be…

Feat. S. Iyer
21:33
SOHO Brazil 2023

2023 SOHO® Brazil: "Laboratory, Molecular & Genetic Finding…

Feat. V. Santini
18:30
SOHO Brazil 2023

2023 SOHO® Brazil: "MDS & AML Classification Updates - Are …

Feat. V. Santini
18:43
SOHO Brazil 2023

2023 SOHO® Brazil: "The Most Up-to-Date CAR-T Results in ALL - …

Feat. B. Shah
27:53
SOHO Brazil 2023

2023 SOHO® Brazil: "How to Sequence Treatment in Second Line CL…

Feat. M. Pavlovsky
14:12
SOHO Brazil 2023

2023 SOHO® Brazil: "Current and Future Roles of Combination The…

Feat. A. Danilov
21:05
SOHO Brazil 2023

2023 SOHO® Brazil: "Enhancing Life Beyond Cancer - Coping Durin…

Feat. F. Penedo
22:17
SOHO Brazil 2023

2023 SOHO® Brazil: "Choosing Frontline Therapy for CLL"

Feat. A. Danilov
15:14
SOHO Brazil 2023

2023 SOHO® Brazil: "Current and Future Approaches to Preventing…

Feat. V. Santini
22:24
SOHO Brazil 2023

How Are Monoclonal Antibodies Transforming ALL Treatment in Adults

Feat. S. Iyer